NCT01837238View on ClinicalTrials.gov

Efficacy of Beta-Hydroxy-Beta-Methylbutyrate (HMB) Supplementation in Hemodialysis Patients

NACompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions
Complication of DialysisChronic Kidney DiseaseMuscle LossEnd Stage Renal Disease
Interventions
DIETARY_SUPPLEMENT

HMB

Following this initial round of testing,participant will be assigned to daily HMB supplementation for 6 months. You will be asked to consume a 1000mg HMB capsule 3 times per day, 7 days per week, for 6 months.

DIETARY_SUPPLEMENT

placebo

The placebo group will consume non-nutritive placebo pills daily for 6 months.

Trial Locations (1)

61822

University of Illinois, Urbana

All Listed Sponsors
lead

University of Illinois at Urbana-Champaign

OTHER

NCT01837238 - Efficacy of Beta-Hydroxy-Beta-Methylbutyrate (HMB) Supplementation in Hemodialysis Patients | Biotech Hunter | Biotech Hunter